Private company

Allozyne

Allozyne was a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation.3 From Wikipedia, CC BY-SA 4.0

Last updated Oct 16, 2026.

Overview

2005Founded1
  • Industrypharmaceutical industry1
  • HeadquartersSeattle1
  • Websitewww.allozyne.com
  • Incorporated inDE4
  • Business address1600 Fairview Ave East, Suite 300, Seattle, Wa 981024

See how the biggest companies compare on our leaderboards

1600 Fairview Ave E, Seattle, Washington, 2014-10-13
Photo: Sage Ross, CC BY-SA 4.0, via Wikimedia Commons5

Allozyne was a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week.3

Leadership

Who has led Allozyne, and when. Pick a name to see everywhere that person has worked.

Timeline

  1. 2014Dissolved Dissolved1
  2. 2005Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5